Phaos Technology Holdings (Cayman) (POAS) Shares Outstanding (2024 - 2025)
Phaos Technology Holdings (Cayman)'s (POAS) quarterly Shares Outstanding (Entity) came in at $25.7 million in Q4 2025, little changed on a QoQ basis from $25.7 million in Q2 2025.
Phaos Technology Holdings (Cayman) (POAS) Shares Outstanding (2024 - 2025) Analysis & Trends
Phaos Technology Holdings (Cayman) (POAS) has 2 years of Shares Outstanding (Entity) data on file, last reported at $25.7 million in Q4 2025.
- Quarterly Shares Outstanding (Entity) changed N/A year-over-year to $25.7 million in Q4 2025, while the trailing twelve-month figure through Oct 2025 was $25.7 million (changed N/A YoY) and the FY2025 annual result came in at $25.7 million, up 0.5% from the prior year.
- Shares Outstanding (Entity) was little changed at $25.7 million in Q4 2025, from $25.7 million in the prior quarter.
- In the past five years, Shares Outstanding (Entity) ranged from a high of $25.7 million in Q2 2025 to a low of $25.6 million in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | 1.74 Bn |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | 383.50 Mn |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | 1.28 Bn |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | 1.47 Bn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | 576.40 Mn |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | 382.20 Mn |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | 453.00 Mn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 955.57 Mn |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | 97.60 Mn |
| 10 | Phaos Technology Holdings (Cayman) | 4.25 Mn | 4.21 Mn | - | 25.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2025 | 25.73 Mn |
| Apr 30, 2025 | 25.66 Mn |
| Apr 30, 2024 | 23.54 Mn |